SYNGAP1 and epilepsy: 2021). Individuals with SYNGAP1‐related disorders often exhibit epilepsy, motor deficits, and pronounced language delays (Bednarczuk et al. 2024; Holder et al. 2019). Although SYNGAP1’s role in BD is speculative, its impact on synaptic plasticity suggests a potential, albeit indirect, link to mood dysregulation.